TRANSPLANTATION PROCEEDINGS移植学论文集
TRANSPLANTATION PROCEEDINGS(英文缩写 TRANSPL P),ISSN 0041-1345,eISSN 1873-2623,中文译名:移植学论文集 是一本学术期刊。本页汇总该期刊的最新影响因子、分区信息以及最新收录于 PubMed 的文献,帮助您快速了解期刊全貌。
发文量统计区间：2025-09-27 至 2026-09-27，按本站收录文献的发表日期统计。
期刊介绍
历年影响因子趋势
| JCR 数据年份 | 影响因子 | JCR 分区 |
|---|---|---|
| 2021 | 1.014 | Q4 |
| 2022 | 0.900 | Q4 |
| 2023 | 0.800 | Q4 |
| 2024 | 0.800 | Q3 |
| 2025 | 0.800 | Q4 |
TRANSPLANTATION PROCEEDINGS 最新收录文献
-
2. Ten-Year Outcomes of Early Suboptimal Graft Function Following Deceased Donor Kidney Transplantation.
PMID:日期:2026-09-18Early graft function is a critical predictor of long-term outcomes in kidney transplantation. This study evaluated 10-year outcomes in patients with suboptimal graft function (SGF) during the first month after deceased donor kidney transplantation (DDKT). In this retrospective study of 294 adult DDKT recipients (February 2006-January 2014), SGF was defined as the lowest serum creatinine >1.5 mg/dL during the first month. Cases with a creatinine ≤1.5 mg/dL were categorized as the standard outcome group. Primary outcomes were 10-year graft and patient survival. Suboptimal graft function was associated with significantly poorer long-term graft survival (5-year: 82.3% vs 92.7%; 10-year: 63.2% vs 89.1%). Overall mortality did not differ between groups. Delayed graft function alone showed no significant association with graft survival. Donor age ≥ 60 years was also associated with inferior graft survival. Suboptimal early creatinine elevation is a significant predictor of long-term graft outcomes. Donor age is an important determinant of long-term graft outcomes.
-
3. Psychiatric and Identity Reconstruction Following Organ Transplantation: A Review of Patient-Attributed Donor-Related Experiences.
PMID:日期:2026-09-18Organ transplantation has increasingly been associated with significant psychological and psychiatric sequelae following surgery. While psychiatric conditions such as anxiety and depression are well documented, some transplant recipients also report changes in personality, behavior, or identity that they attribute to the controversial concept of "cellular memory." This narrative review evaluates reported psychiatric and psychological changes following organ transplantation and examines explanatory models beyond the concept of "cellular memory." A narrative review of literature published between 1997 and 2025 was conducted using the ScienceDirect, PubMed, and SciLit databases. Studies describing posttransplant psychiatric symptoms, personality changes, or identity reconstruction were included. A total of six studies met inclusion criteria and were analyzed. Reported phenomena included mood disturbances, identity changes, altered preferences, and memory-like experiences that recipients attributed to donor characteristics. These reported experiences were primarily subjective, inconsistently reproduced, and derived from low-level evidence. No empirically supported biological mechanism for the transfer of memory or personality through organ transplantation was identified. Although current evidence does not support "cellular memory" as a biological phenomenon, recipient-reported psychological experiences remain clinically relevant. These findings highlight the importance of addressing psychiatric symptoms as part of comprehensive posttransplant care and support integration of psychiatric screening and counseling into posttransplant care.
-
4. Latent Profile Analysis of Symptom Experiences in Kidney Transplant Recipients and Their Differences in Health-Related Quality of Life: A Cross-Sectional Study.
PMID:日期:2026-09-17To explore the latent profiles of symptom experience in kidney transplant recipients, examine their influencing factors, and compare the differences in health-related quality of life across distinct symptom experience profiles. A total of 345 kidney transplant recipients were recruited from a tertiary Grade A hospital in Guizhou Province via convenience sampling. All participants finished the General Information Questionnaire, Symptom Experience Scale and 12-Item Short Form Health Survey. Latent profile analysis was employed to classify recipients into subgroups based on their symptom experiences. Univariate analysis and multivariate logistic regression were applied to explore factors associated with distinct latent profiles, and health-related quality of life was compared across subgroups. Three latent profiles of symptom experience were identified: the mild symptom group (53.9%), the moderate symptom group (27.3%), and the severe symptom group (18.8%). Logistic regression analysis showed that gender, employment status, number of post-transplant rehospitalizations and number of comorbidities were significant influencing factors of profile membership (all P < .05). Statistically significant differences were observed across the 3 profiles in both the Physical Component Summary and Mental Component Summary scores of health-related quality of life (all P < .05). Symptom experience in kidney transplant recipients is heterogeneous, and health-related quality of life varies across different symptom experience profiles. Clinical nursing staff can implement targeted symptom management strategies for patients in different subgroups to alleviate symptom burden and improve their quality of life.
-
5. Survival of Hepatocellular Carcinoma After Liver Transplantation: Validation of Malatya Criteria.
PMID:日期:2026-09-17The aim of this study is to evaluate the effectiveness of The Malatya criteria, a novel set of criteria applied in consideration of patients with cirrhosis and hepatocellular carcinoma (HCC) in liver transplantation (LT). Patients who underwent liver transplantation for HCC between 2007 and 2022 were reviewed. HCC recurrence rate and survival (both overall survival (OS) and disease free survival (DFS) analyses were made according to Milan and Malatya criteria. 5-year recurrence rate, OS and DFS were 6.2%, 72.6%, and 73% within Milan criteria and 7.6%, 67.6%, and 68% within Malatya criteria respectively. Additionally, Malatya group had 16,5% expansion rate instead of Milan DISCUSSION AND CONCLUSION: Malatya criteria has remarkable expansion rate and acceptable survival and recurrence rate for the selection of HCC for LT.
-
6. Knowledge Gaps and Educational Needs in Organ Donation: A Cross-Sectional Study Among Patients With End-Stage Renal Disease and Their Families.
PMID:日期:2026-09-16Insufficient knowledge has been consistently identified as a major barrier to organ donation, influencing attitudes, perceptions, and willingness to participate. To assess knowledge levels regarding organ donation among patients with end-stage renal disease (ESRD) and their relatives, and to identify educational needs associated with organ donation attitudes and willingness. A cross-sectional questionnaire-based study was conducted between December 2020 and September 2021 at 2 tertiary healthcare centers in Greece: the University General Hospital of Alexandroupolis and the General Hospital of Komotini (Sismanoglio). A total of 178 participants were included, comprising 104 patients with end-stage renal disease (ESRD) and 74 relatives. Adult patients with ESRD receiving dialysis treatment and accompanying adult relatives were recruited using convenience sampling. Data were collected using a structured questionnaire assessing knowledge, awareness, and attitudes toward organ donation. Associations between categorical variables were analyzed using chi-square (χ²) tests, with statistical significance set at p < .05. A substantial proportion of participants demonstrated insufficient knowledge regarding organ donation (58%). The most common misconceptions included misunderstanding eligibility criteria (45%), lack of awareness of donation procedures (52%), and incorrect perceptions of organ allocation systems (39%). Lower knowledge levels were significantly associated with reduced willingness to donate organs (p = .01) and greater hesitation toward organ donation (p = .02). Relatives demonstrated lower knowledge levels than patients (61% vs. 55%, p = .04). Higher knowledge levels were significantly associated with more positive attitudes toward organ donation (p = .01). Knowledge levels were significantly associated with organ donation attitudes and willingness among patients with ESRD and their relatives. Relatives demonstrated lower knowledge levels than patients. These findings highlight the importance of educational needs within this population and may help inform future educational initiatives, public health strategies, and further research.
-
7. Risk Factors for Acute Kidney Injury After Conventional Open Liver Transplantation: A Single-Center Retrospective Cohort Study.
PMID:日期:2026-09-16Acute kidney injury (AKI) is frequent after liver transplantation (LT). We evaluated its incidence, risk factors, and survival impact. We retrospectively analyzed 341 adult recipients who underwent conventional open LT between January 2019 and January 2024. Patients undergoing nonstandard implantation techniques, laparoscopic-assisted LT, combined liver-kidney transplantation, or retransplantation, as well as those with pretransplant eGFR <30 mL/min/1.73 m or incomplete data, were excluded. AKI occurred in 54.3% (stage 1, 39.6%; stage 2, 9.4%; stage 3, 5.3%). The modified piggyback technique was associated with a lower incidence of AKI than classical caval replacement (47.1% vs 61.5%, P = .01). Multivariable analysis identified surgical technique, donor ICU stay, donor weight, operative time, and cumulative duration of MAP <65 mm Hg as independent factors associated with AKI. One-year survival was lower in the AKI group (82.4% vs 93.3%; P = .003). Post-LT AKI was common and associated with increased 1-year mortality. Surgical technique, donor ICU stay, donor weight, operative time, and intraoperative hypotension were independently associated with AKI risk. These findings highlight potentially modifiable perioperative factors relevant to post-LT AKI risk.
-
8. Influence of Donor Age on Graft and Patient Outcomes in Kidney Transplantation: A Systematic Review and Meta-Analysis.
PMID:日期:2026-09-16Kidney transplantation remains the optimal treatment for end-stage renal disease. With rising use of older donors to expand the organ pool, concerns have emerged about the impact of donor age on transplant outcomes. To systematically evaluate the influence of donor age on graft and patient survival following kidney transplantation. We conducted a systematic review and meta-analysis following PRISMA 2020 guidelines. Literature searches were performed in PubMed, Scopus, Embase, and Cochrane up to April 2025. Eligible studies included cohort or case-control designs reporting outcomes stratified by donor age. Outcomes assessed included death-censored graft survival, patient survival, delayed graft function, and acute rejection. Hazard ratios (HRs) were pooled using random-effects models when heterogeneity (I²) exceeded 50%. Seven studies involving 19,210 transplant recipients were included. Older donor age was significantly associated with an increased risk of death-censored graft loss (HR 1.73; 95% CI: 1.34-2.24) and higher patient mortality (HR 1.42; 95% CI: 1.05-1.94), particularly in the subgroup of donors aged >60 years. Heterogeneity was moderate across studies (I² = 61% for graft loss; I² = 73% for patient survival). No significant difference was observed in acute rejection rates between older and younger donor groups (OR 0.86; 95% CI: 0.60-1.23). The analysis was limited by the small number of observational studies (n = 7), with potential residual confounding and clinical heterogeneity that may affect the generalizability of the findings. Donor age, particularly over 60 years, is associated with poorer graft and recipients outcomes. Despite this, older donors can be acceptable with proper recipient selection and age-matching strategies. Further studies with standardized age thresholds and long-term follow-up are needed to guide allocation policy.
-
9. Efficacy and Safety of Paricalcitol Therapy for Kidney Transplantation Recipients: A Systematic Review and Meta-analysis of Randomized Controlled Trials.
PMID:日期:2026-09-16To evaluate the efficacy and safety of paricalcitol in kidney transplant recipients while accounting for the small and clinically heterogeneous randomized evidence base. The original multi-database search was supplemented by targeted PubMed and ClinicalTrials.gov surveillance through July 6, 2026. Eligible randomized trials comparing paricalcitol with inactive control were synthesized using random-effects models with small-sample-adjusted confidence intervals. Six randomized trials involving 482 recipients were included. Paricalcitol reduced parathyroid hormone (SMD, -0.74; 95% CI, -1.23 to -0.24; p = .01; I² = 52%) but did not show a clear reduction in proteinuria (SMD, -0.22; 95% CI, -0.50 to 0.06; p = .10; I² = 0%). Serum calcium increased (SMD, 0.36; 95% CI, 0.03 to 0.68; p = .04; I² = 25%), and hypercalcemia was more frequent (RR, 3.71; 95% CI, 1.21 to 11.36; p = .03; I² = 0%). Serum phosphorus (SMD, 0.11; 95% CI, -0.18 to 0.40; p = .34; I² = 0%) and rejection events (RR, 0.78; 95% CI, 0.10 to 6.45; p = .67; I² = 0%) remained inconclusive. Paricalcitol lowers short-term parathyroid hormone but increases serum calcium and hypercalcemia risk. Evidence for proteinuria, rejection, graft survival, and patient outcomes remains insufficient because the trials were few, heterogeneous, and short.
-
10. Donor Acute Kidney Injury and Short- and Long-Term Graft Outcomes After Deceased Donor Kidney Transplantation: A Retrospective Single-Center Study.
PMID:日期:2026-09-16Deceased donor kidney transplantation (DKT) remains an important treatment for end-stage kidney disease, but increasing reliance on marginal donors, including those with acute kidney injury (AKI), has raised concern regarding post-transplant outcomes. We evaluated the association between donor AKI and adverse long-term graft outcomes after DKT. This retrospective single-center cohort study included 143 deceased donor kidney transplant recipients who underwent DKT between June 1, 2014 and December 31, 2023, with follow-up through December 31, 2024. Donor and recipient demographic and clinical variables were extracted from institutional records. The study outcomes, graft failure and graft rejection, were assessed in relation to donor AKI, donor and recipient clinical characteristics, and donor category. Among 143 recipients, 93 (65.0%) received kidneys from donors with AKI. Graft failure occurred in 16.1% of recipients in the donor AKI group versus 10.0% in the non-AKI group (OR 1.73, 95% CI 0.59-5.08; P = .449). Median time to graft loss was shorter in the donor AKI group (2.18 vs 7.44 years; P = .101). Graft rejection occurred in 23.7% vs 30.0% of recipients, respectively (OR 0.72, 95% CI 0.33-1.56; P = .429). Rejection episodes clustered earlier in the donor AKI group, and serum creatinine was significantly higher at 6 months (P = .031), but not at later follow-up. Donor category, delayed graft function subgrouping, and recipient baseline clinical factors, including age, sex, body mass index, diabetes, and hypertension, were not significantly associated with graft outcomes. Donor AKI was associated with numerically less favorable graft outcomes, earlier graft loss, and higher 6-month serum creatinine after DKT, although these associations did not reach statistical significance for graft failure or rejection. These findings provide exploratory clinical insight and support close post-transplant surveillance of recipients of kidneys from donors with AKI. Larger multicenter studies are needed to validate these observations.